|
|
Article: Forbes Medi-Tech Announces Financial Results for Third Quarter Ended September 30, 2009.
- Article from:
- Marketwire Canada
- Article date:
- November 9, 2009
CopyrightCOPYRIGHT 2009 Canadian Corporate News. News Provided by Comtex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
VANCOUVER, BRITISH COLUMBIA, Nov 9, 2009 (Marketwire via COMTEX) -- Forbes Medi-Tech Inc. (NASDAQ:FMTI) ("Forbes" or "Company") today announced its results for the third quarter ended September 30, 2009. The comparative period for these statements is the three and nine-month periods ended September 30, 2008. All amounts are in Canadian Dollars unless otherwise noted.
THIRD QUARTER OVERVIEW:
Reducol(TM): In October 2009 the Company announced that the European Union had approved a health claim for plant sterols -- Reducol(TM) -- in free or esterified form.
Exchange Listings: In January 2009, Forbes announced that it had received notice from the ...
Related newspaper, magazine, and journal articles:
|
|
Article: AMVESCAP Reports Results for Nine Months Ended ...
Business Wire;
October 25, 2006 ;
700+ words
... ... operating margin for the three months ended September 30, 2006, was 26.7% (three ... improved performance in 2006, the company now projects that this earnings ... Client cash for the nine months ended September 30, 2006, decreased $224.1 ...
|
|